Latest filing published 29 May 2026 for Edesa Biotech, Inc..
No signal scores available.
Charles Olson V is a declared insider of Edesa Biotech, Inc., with filings sourced from SEC (Form 4). In total, 2 filings cover trades dated from 29 May 2025 to 27 May 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 29 May 2026 came the latest disclosure, a share grant in Edesa Biotech, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations